Motor protein regulation of T cell receptor signaling
T 细胞受体信号传导的运动蛋白调节
基本信息
- 批准号:7648345
- 负责人:
- 金额:$ 41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-10 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAntigen ReceptorsAntigen-Presenting CellsAntigensAutoimmune DiseasesB-LymphocytesBiochemicalBiological AssayCell LineCell ProliferationCell membraneCell physiologyCellsComplexCuesDevelopmentGene ExpressionGrowthHumanHyperactive behaviorImageImmuneImmune System DiseasesImmune responseImmune systemImmunologic Deficiency SyndromesKinesinLeukocytesLymphocyteMediatingMicrotubule-Organizing CenterMicrotubulesMolecularMolecular TargetMotorMutationNF-kappa BOncogenicPathway interactionsPatternProcessProteinsRNA InterferenceReagentReceptor SignalingReceptors, Antigen, B-CellRegulationReportingResistanceRoleSet proteinSignal PathwaySignal TransductionStimulusSynapsesT Cell Receptor Signaling PathwayT-Cell ReceptorT-LymphocyteTestingTranslatingadapter proteinagedcancer typecell typecofactordesignexpression cloningimmunological synapselarge cell Diffuse non-Hodgkin&aposs lymphomalentiviral-mediatedmutantnoveloverexpressionpathogenprogramspublic health relevancereceptorresearch studyscaffoldtherapy designtranscription factor
项目摘要
DESCRIPTION (provided by applicant): The engagement of the T cell receptor (TCR) on T lymphocytes initiates signaling pathways that regulate cell proliferation, activation, and survival through the activation of transcription factors that regulate programs of gene expression. TCR signaling is initiated when an antigen presenting cell (APC) presents antigen, in the appropriate molecular context, to a T cell. After APC:T cell conjugation, the immunological synapse forms in the region of cell:cell contact. Signaling from the synapse to transcription factors requires the recruitment of signaling intermediates to the immunological synapse in a process that is incompletely understood. CARD11 is a multi-domain adapter protein that coordinates the signal-induced association of a set of proteins that are required for TCR-mediated activation of NF-kappaB. In order to expand our understanding of how CARD11 relays signals from the TCR to NF-kappaB, we have developed a novel expression cloning strategy for the identification of modulators of CARD11 signaling activity. Using this strategy, we isolated the kinesin-like motor protein GAKIN as a negative regulator of CARD11. In our preliminary studies, we have determined that GAKIN overexpression inhibits CARD11 activity and TCR signaling while the reduction in GAKIN expression results in enhanced CARD11 and TCR signaling. GAKIN and CARD11 associate at endogenous levels in T cells in a signal-inducible manner. Imaging studies suggest that the cellular localization of GAKIN changes during TCR signaling, which may depend on GAKIN's ability as a motor protein to move cargo along microtubules. In this application, we propose to test our overall hypothesis that GAKIN is a critical negative regulator of TCR signaling that regulates the scaffolding function and cellular localization of CARD11. Using biochemical approaches, we will investigate which domains of GAKIN are required for its association with CARD11 and for its ability to negatively regulate TCR signaling. We will also determine whether GAKIN modulates the association of signaling cofactors with CARD11. In imaging experiments, we will characterize how the localization of GAKIN is determined and whether GAKIN regulates the recruitment of CARD11 and signaling factors to the immunological synapse. GAKIN associates with CARD11 in a region in which oncogenic mutations have been found in Diffuse Large B cell Lymphoma (DLBCL). We will investigate whether these mutations affect GAKIN-mediated regulation of CARD11 activity and determine whether GAKIN can inhibit the dysregulated growth in DLBCL. Our results should add to the understanding of how the molecular machinery of immune cells can recognize and interpret environmental cues, including pathogenic and nonpathogenic stimuli, and respond appropriately. Since this machinery is impaired in aged T cells, dysregulated in immunodeficiencies, and is abnormally hyperactive in autoimmune disease and in several types of cancer, our results may illuminate molecular targets for the development of new therapies designed to treat multiple diseases of the immune system. PUBLIC HEALTH RELEVANCE: The normal function of the immune system depends on the ability of white blood cells, or lymphocytes, to detect foreign pathogens and respond appropriately so that a pathogen is eliminated without damage to the host. This proposal is designed to expand understanding of the molecular machinery that is used by T lymphocytes in this process. Since this machinery is impaired in aged T cells, dysregulated in immunodeficiencies, and is abnormally hyperactive in autoimmune disease and in several types of cancer, our results may illuminate molecular targets for the development of new therapies designed to treat multiple diseases of the immune system.
描述(由申请人提供):T淋巴细胞上T细胞受体(TCR)的参与启动信号传导途径,通过激活调节基因表达程序的转录因子来调节细胞增殖、活化和存活。当抗原呈递细胞(APC)在适当的分子背景下将抗原呈递给T细胞时,TCR信号传导被启动。APC:T细胞结合后,免疫突触在细胞:细胞接触区域形成。从突触到转录因子的信号传导需要募集信号传导中间体到免疫突触,这一过程还不完全清楚。CARD 11是一种多结构域衔接蛋白,其协调TCR介导的NF-κ B活化所需的一组蛋白质的信号诱导的缔合。为了扩大我们对CARD 11如何将信号从TCR传递到NF-κ B的理解,我们开发了一种新的表达克隆策略来鉴定CARD 11信号活性的调节剂。使用这种策略,我们分离出驱动蛋白样运动蛋白GAKIN作为CARD 11的负调节因子。在我们的初步研究中,我们已经确定GAKIN过表达抑制CARD 11活性和TCR信号传导,而GAKIN表达减少导致CARD 11和TCR信号传导增强。GAKIN和CARD 11以信号诱导的方式在T细胞中以内源性水平缔合。影像学研究表明,GAKIN的细胞定位在TCR信号传导过程中发生变化,这可能取决于GAKIN作为马达蛋白沿着微管移动货物的能力。在本申请中,我们提出测试我们的总体假设,即GAKIN是TCR信号传导的关键负调节因子,其调节CARD 11的支架功能和细胞定位。使用生物化学方法,我们将研究GAKIN的哪些结构域是其与CARD 11的关联所必需的,以及其负调节TCR信号传导的能力。我们还将确定GAKIN是否调节信号辅因子与CARD 11的关联。在成像实验中,我们将描述GAKIN的定位是如何确定的,以及GAKIN是否调节CARD 11和信号传导因子向免疫突触的募集。GAKIN在弥漫性大B细胞淋巴瘤(DLBCL)中发现致癌突变的区域与CARD 11相关。我们将研究这些突变是否影响GAKIN介导的CARD 11活性调节,并确定GAKIN是否可以抑制DLBCL中的失调生长。我们的研究结果应该有助于理解免疫细胞的分子机制如何识别和解释环境线索,包括致病性和非致病性刺激,并做出适当的反应。由于这种机制在老年T细胞中受损,在免疫缺陷中失调,并且在自身免疫性疾病和几种类型的癌症中异常活跃,我们的研究结果可能会阐明用于开发旨在治疗多种免疫系统疾病的新疗法的分子靶点。公共卫生相关性:免疫系统的正常功能取决于白色血细胞或淋巴细胞检测外来病原体并做出适当反应的能力,以便在不损害宿主的情况下消除病原体。该建议旨在扩大对T淋巴细胞在此过程中使用的分子机制的理解。由于这种机制在老年T细胞中受损,在免疫缺陷中失调,并且在自身免疫性疾病和几种类型的癌症中异常活跃,我们的研究结果可能会阐明用于开发旨在治疗多种免疫系统疾病的新疗法的分子靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joel L Pomerantz其他文献
Joel L Pomerantz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joel L Pomerantz', 18)}}的其他基金
Targeting a Membrane Protease that Controls NK Cell Maturation
靶向控制 NK 细胞成熟的膜蛋白酶
- 批准号:
10631217 - 财政年份:2022
- 资助金额:
$ 41万 - 项目类别:
Targeting a Membrane Protease that Controls NK Cell Maturation
靶向控制 NK 细胞成熟的膜蛋白酶
- 批准号:
10506509 - 财政年份:2022
- 资助金额:
$ 41万 - 项目类别:
Mechanisms of Control of Lymphocyte Activation and Proliferation by a Critical Signaling Integrator
关键信号整合器控制淋巴细胞激活和增殖的机制
- 批准号:
10063977 - 财政年份:2019
- 资助金额:
$ 41万 - 项目类别:
Mechanisms of Control of Lymphocyte Activation and Proliferation by a Critical Signaling Integrator
关键信号整合器控制淋巴细胞激活和增殖的机制
- 批准号:
10528445 - 财政年份:2019
- 资助金额:
$ 41万 - 项目类别:
Mechanisms of Control of Lymphocyte Activation and Proliferation by a Critical Signaling Integrator
关键信号整合器控制淋巴细胞激活和增殖的机制
- 批准号:
10304147 - 财政年份:2019
- 资助金额:
$ 41万 - 项目类别:
Regulation of CARD11 signaling in normal and dysregulated lymphocyte development
CARD11 信号在正常和失调淋巴细胞发育中的调节
- 批准号:
8704412 - 财政年份:2013
- 资助金额:
$ 41万 - 项目类别:
Regulation of CARD11 signaling in normal and dysregulated lymphocyte development
CARD11 信号在正常和失调淋巴细胞发育中的调节
- 批准号:
9056446 - 财政年份:2013
- 资助金额:
$ 41万 - 项目类别:
Regulation of CARD11 signaling in normal and dysregulated lymphocyte development
CARD11 信号在正常和失调淋巴细胞发育中的调节
- 批准号:
8829795 - 财政年份:2013
- 资助金额:
$ 41万 - 项目类别:
Regulation of CARD11 signaling in normal and dysregulated lymphocyte development
CARD11 信号在正常和失调淋巴细胞发育中的调节
- 批准号:
8554256 - 财政年份:2013
- 资助金额:
$ 41万 - 项目类别:
Motor protein regulation of T cell receptor signaling
T 细胞受体信号传导的运动蛋白调节
- 批准号:
8099462 - 财政年份:2009
- 资助金额:
$ 41万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 41万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 41万 - 项目类别:
Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 41万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 41万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 41万 - 项目类别:
Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 41万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 41万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 41万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 41万 - 项目类别:
Research Grant